Clinical Trial Update: Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety and potential efficacy of nebulized extracellular vesicles derived from 3D-cultured human placental mesenc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Nebulized hPMSC-EVs (human placental mesenchymal stem cell-derived extracellular vesicles)

Snippet

Sponsor: Huan Ye | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 1 | Status: NOT_YET_RECRUITING